Evidence map›Paper›PMID 20822968›Full record

Trial reportEnvironmental health perspectives2010

Vascular effects of ultrafine particles in persons with type 2 diabetes.

Judith C Stewart, David C Chalupa, Robert B Devlin, Lauren M Frasier, Li-Shan Huang, Erika L Little, Steven M Lee, Richard P Phipps, Anthony P Pietropaoli, Mark B Taubman and 2 more

Open access · diamondAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Environmental health perspectives, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Longitudinal changes in cardiovascular disease-related proteins in welders.International archives of occupational and environmental health · 2024
    Article
  7. Review
  8. [Effects of ultrafine particulates on cardiac function in rat isolated heart].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2021
    Article
  9. Cardiovascular adaptations to particle inhalation exposure: molecular mechanisms of the toxicology.American journal of physiology. Heart and circulatory physiology · 2020
    Review
  10. Article
  11. Article
  12. In Vitro and In Vivo Experimental Studies of PMInternational journal of environmental research and public health · 2018
    Review
  13. Ambient air pollution and thrombosis.Particle and fibre toxicology · 2018
    Review
  14. Occupational exposure to ultrafine particles in police officers: no evidence for adverse respiratory effects.Journal of occupational medicine and toxicology (London, England) · 2018
    Article
  15. Article
  16. Article
  17. Ambient Particulate Matter (PMJournal of epidemiology · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Judith C StewartDepartment of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA.
David C Chalupa
Robert B Devlin
Lauren M Frasier
Li-Shan Huang
Erika L Little
Steven M Lee
Richard P Phipps
Anthony P Pietropaoli
Mark B Taubman
Mark J Utell
Mark W Frampton
University of Rochester Medical Center · USEnvironmental Protection Agency · US

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Martha Susiarjo · 1985 to 2026
$42.8M
UNIVERSITY OF ROCHESTER'S RESEARCH ASSOCIATE ORGANIZATIONUL1RR024160 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$38.7M
Ultrafine Particle-Induced Oxidative StressR01ES013394 · NIEHS · UNIVERSITY OF ROCHESTER · PI FRAMPTON, MARK WALTER · 2004 to 2007
$1.5M
Platelet Activation and Inflammatory MediatorsR01HL078603 · NHLBI · UNIVERSITY OF ROCHESTER · PI PHIPPS, RICHARD P. · 2004 to 2007
$1.2M
Ozone Cardiovascular Effects in Genetically Susceptible PeopleR01ES017428 · NIEHS · UNIVERSITY OF ROCHESTER · PI FRAMPTON, MARK WALTER · 2010 to 2012
$1.0M
Cardiovascular Effects of Ultrafine Particles in Genetically Susceptible SubjectsRC1ES018519 · NIEHS · UNIVERSITY OF ROCHESTER · PI FRAMPTON, MARK WALTER · 2009 to 2010
$1000k
NCRR NIH HHS UL1 RR024160NHLBI NIH HHS R01 HL078603NIEHS NIH HHS P30 ES001247NIEHS NIH HHS P30 ES01247NIEHS NIH HHS R01 ES013394NIEHS NIH HHS R01 ES017428NIEHS NIH HHS RC1 ES018519
6 · The paper itself

Abstract

backgroundDiabetes confers an increased risk for cardiovascular effects of airborne particles.

objectiveWe hypothesized that inhalation of elemental carbon ultrafine particles (UFP) would activate blood platelets and vascular endothelium in people with type 2 diabetes.

methodsIn a randomized, double-blind, crossover trial, 19 subjects with type 2 diabetes inhaled filtered air or 50 µg/m³ elemental carbon UFP (count median diameter, 32 nm) by mouthpiece for 2 hr at rest. We repeatedly measured markers of vascular activation, coagulation, and systemic inflammation before and after exposure.

resultsCompared with air, particle exposure increased platelet expression of CD40 ligand (CD40L) and the number of platelet-leukocyte conjugates 3.5 hr after exposure. Soluble CD40L decreased with UFP exposure. Plasma von Willebrand factor increased immediately after exposure. There were no effects of particles on plasma tissue factor, coagulation factors VII or IX, or D-dimer.

conclusionsInhalation of elemental carbon UFP for 2-hr transiently activated platelets, and possibly the vascular endothelium, in people with type 2 diabetes.

Indexed as

AdultAge FactorsAir PollutantsBlood VesselsCarbonCD40 LigandCoagulantsCross-Over StudiesDiabetes Mellitus, Type 2Double-Blind MethodFemaleHumansMaleMiddle AgedParticulate MatterP-SelectinAir PollutantsCarbonCD40 LigandCoagulantsParticulate MatterP-Selectinvon Willebrand Factor

Identifiers

PMID20822968
PMCPMC3002188
OpenAlexW2020597330

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.